Mime-Version: |
1.0 |
Sender: |
|
Subject: |
|
From: |
|
Date: |
Sun, 2 Aug 1998 09:46:11 EDT |
Content-transfer-encoding: |
7bit |
Content-type: |
text/plain; charset=US-ASCII |
Reply-To: |
|
Parts/Attachments: |
|
|
In a message dated 98-08-02 00:10:40 EDT, you write:
<< Having had a client this
year who had a near fatal anaphylatic episode following the ingestion of
formula (and he had the classic history...just a few "top offs" in the
early weeks), I firmly believe that fromula is a significant risk to an
infant. Time to check that research carefully for flaws.
>>
The most obvious flaw is that the control group was not exclusively breastfed.
The study compared two groups of babies that received ABM for three days -
one group got "regular" ABM, the other ABM without the protein. Both groups
breastfed after three days. Okay, so this indicates that *if* a baby is to
get ABM it might as well be "regular" ABM - but the authors make a huge leap
to conclude that ABM doesn't predispose babies to allergy when they didn't
check the rate of allergy in exclusively breastfed babies. If this makes
*any* sense to the rest of you please explain it to me.
Elaine Ziska, LLLL
|
|
|